Big Data/AI/Machine Learning
Souvik Bhattacharya, PhD (he/him/his)
Associate Director
Astellas Pharma
Weymouth, Massachusetts, United States
Hu Huang, PhD (he/him/his)
Associate Director
Astellas Pharma, United States
Jiawei Zhou, PhD (she/her/hers)
Assistant Professor
UNC-Chapel Hill, North Carolina, United States
Ahmed Elmokadem, PhD
Senior Scientist II
Metrum Research Group, United States
Rajat Desikan, PhD (he/him/his)
Director
GSK (UK)
Rotherham, England, United States
Lorenzo Contento, PhD (he/him/his)
Product Engineer
Pumas-AI Inc., Italy
Description of session (include background & scientific importance): With the advances in digital platforms, AI/ML is evolving as an important tool in drug development. Broadening the knowledge of clinical pharmacology by leveraging data and using modelling and statistical tools has proven to be effective in drug development by reducing both the cost and the time required to bring a drug to patients. The progress in the field of AI/ML has supported model-informed drug development (MIDD) by promoting synergistic techniques alongside the traditional approaches of exposure-response analyses. A widely used application of AI/ML, which proved to be advantageous in several aspects of drug development, is covariate selection. Effective covariate selection is essential for developing robust, interpretable, and generalizable models from the complex datasets commonly encountered in pharmacometrics.
This tutorial will connect general machine learning principles with their specific applications in pharmacometrics and modelling, with a focus on practical variable selection strategies.
Draft agenda of the tutorial is as follows:
1) Introduction to strategies for selecting explanatory variables in Exposure-Response Analysis Using Machine Learning
Souvik Bhattacharya
2) Use Machine Learning for Covariate Selection in Population Mode
Jiawei Zhou
3) Hierarchical Deep Compartment Modeling: Integrating Deep Learning, SHAP Analysis, and Bayesian Inference in Julia
Ahmed Elmokadem
4) Machine learning applied to Hepatitis B virtual patients suggests prognostic biomarker signatures for stratifying responders to standard-of-care therapies.
Rajat Desikan
Hands-on AI/ML application to select covariates organized by Souvik Bhattacharya and Hu Huang.
Instructor: Souvik Bhattacharya, PhD (he/him/his) – Astellas Pharma
Instructor: Jiawei Zhou, PhD (she/her/hers) – UNC-Chapel Hill
Instructor: Rohit Rao, NA – Pfizer Inc.
Instructor: Ahmed Elmokadem, PhD – Metrum Research Group
Instructor: Rajat Desikan, PhD (he/him/his) – GSK (UK)
Instructor: Lorenzo Contento, PhD (he/him/his) – Pumas-AI Inc.
Instructor: Souvik Bhattacharya, PhD (he/him/his) – Astellas Pharma